Group letter re: DEA’s proposed rule on controlled substances quotas

May 4, 2018

RE: Controlled Substances Quotas [Docket No. DEA-480]

The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas. Although we support DEA’s efforts to combat diversion, we are concerned that the proposed rule is focused on diversion to the exclusion of another critical factor – drug shortages. To ensure that legitimate medical needs are met, it is imperative that drug shortages be considered as aggregate production quotas (APQ) are set and adjusted.


Read the full letter below.

Related Resources

Advisory
Member
On Dec. 21, the Centers for Medicare…
Advocacy Webinar Recording
Member
On January 11, the AHA held a webinar for members on the Centers for Medicare & Medicaid Services' December.
Magazine/Newspaper/Website
Public
January 2019 -- Adapting existing technology, the Texas Hospital Association is helping health care providers in Texas fight the state's opioid epi
Letter
Public
AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and…
Webinar Recordings
Member
The final rule updates physician fee schedule payments for CY 2019 and finalizes several policies to implement year three of the Quality Payment Program…
Advisory
Member
Download the full Regulatory Advisory (PDF) below